To the editor: Multiple myeloma (MM) is the second most common hematologic malignancy in the United States (US), representing 1.4% of all new cancers,[1][1] and is twice as common among African Americans as it is among other racial or ethnic groups.[2][2] Although the absolute burden (or number) of
No takes yet. Share an insight, caveat, or question.
Rosenberg et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: